|
Dr. Eugene
Van Scott and Dr. Ruey Yu are
Co-Founders of The NeoStrata Company, Inc.,
and co-discoverers of the benefits of using
AHAs, PHAs, and Bionics on hyperkeratotic and
photo-aged skin.
Dr. Van Scott
has been a board-certified dermatologist for
over 50 years, and established the
dermatology branch for the National Cancer
Institute, serving as its chief for 15
years. He has played formative roles in the
Dermatology Foundation, the National
Psoriasis Foundation, and the Society for
Investigative Dermatology. Dr. Van Scott has
received numerous prestigious awards,
including The Albert Lasker Award (sometimes
referred to as an "American Nobel prize")
for outstanding research achievements in
skin cancer, Master in Dermatology by the
American Academy of Dermatology, and a
Distinguished Ser vice
Medallion, the highest honor awarded by The
Dermatology Foundation. He has published
more than 175 scientific and medical
publications, and participates as a member
or honorary member on more than 15
dermatological societies.
Dr. Yu
was born in Taiwan, and received both a
Japanese and Chinese education. He holds a
doctorate in chemistry from University of
Ottawa (Canada), and a post-doctoral
fellowship at the National Research Council
of Canada. Dr. Yu specializes in dermatopharmacology and skin biochemistry,
and is an Associate Professor at the Skin &
Cancer Hospital, Temple University. He has
also received a Doctorate of Oriental
Medicine, and is licensed to practice
acupuncture. Among other awards, Dr. Yu is
the recipient of the Foundation for Ichthyosis & Related Skin Types (FIRST) 2008
Testimonial Award Dinner honoring both Dr.
Yu and Dr. Van Scott for their significant
contributions in the treatment of ichthyosis.
Dr. Yu has published more than 40 scientific
and medical publications, and is a frequent
speaker at scientific symposia.
In their
partnership, Dr. Van Scott provides a
clinical role, while Dr Yu offers expertise
in chemistry and innovation. Together,
they have accumulated many patents
pertaining to treatments of dermatologic
disorders.
.
|
